SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001562762-23-000410
Filing Date
2023-11-08
Accepted
2023-11-08 07:53:21
Documents
75
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vaxx-20230930.htm   iXBRL 10-Q 1164513
7 EX-31.1 exhibit311.htm EX-31.1 11425
8 EX-31.2 exhibit312.htm EX-31.2 11510
9 EX-32.1 exhibit321.htm EX-32.1 6182
  Complete submission text file 0001562762-23-000410.txt   6464833

Data Files

Seq Description Document Type Size
2 EX-101.SCH vaxx-20230930.xsd EX-101.SCH 76093
3 EX-101.CAL vaxx-20230930_cal.xml EX-101.CAL 67089
4 EX-101.DEF vaxx-20230930_def.xml EX-101.DEF 411304
5 EX-101.LAB vaxx-20230930_lab.xml EX-101.LAB 716185
6 EX-101.PRE vaxx-20230930_pre.xml EX-101.PRE 528228
69 EXTRACTED XBRL INSTANCE DOCUMENT vaxx-20230930_htm.xml XML 713062
Mailing Address 505 ODYSSEY WAY EXPLORATION PARK FL 32953
Business Address 505 ODYSSEY WAY EXPLORATION PARK FL 32953 (254) 244-5739
Vaxxinity, Inc. (Filer) CIK: 0001851657 (see all company filings)

IRS No.: 862083865 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41058 | Film No.: 231386014
SIC: 2834 Pharmaceutical Preparations